June Sherie Almenoff Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

June Sherie Almenoff is Director of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 6,000 shares of BCLI, which is worth approximately $9,300. The most recent transaction as insider was on Dec 15, 2021, when has been sold 2,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K

0% 3M change

0% 12M change

Total Value Held $9,300

June Sherie Almenoff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 15 2021	BUY Grant, award, or other acquisition	-	2,000 Added 25.0%	6,000 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	2,000 Added 33.33%	4,000 Common Stock

Also insider at

TENX

TENAX THERAPEUTICS, INC. Healthcare

AVTX

Avalo Therapeutics, Inc. Healthcare

Director

ATNM

Actinium Pharmaceuticals, Inc. Healthcare

Director

JSA